Sonoma Pharmaceuticals, Inc.
SNOA
$2.79
$0.8040.20%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.42% | 5.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.42% | 5.54% | |||
| Cost of Revenue | 3.43% | 6.38% | |||
| Gross Profit | -6.69% | 4.21% | |||
| SG&A Expenses | 9.91% | -15.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.75% | -2.96% | |||
| Operating Income | -21.29% | 27.54% | |||
| Income Before Tax | -98.49% | 53.56% | |||
| Income Tax Expenses | -93.88% | 0.68% | |||
| Earnings from Continuing Operations | -52.13% | 46.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.13% | 46.63% | |||
| EBIT | -21.29% | 27.54% | |||
| EBITDA | -22.45% | 28.13% | |||
| EPS Basic | -7.46% | 56.06% | |||
| Normalized Basic EPS | -40.16% | 61.75% | |||
| EPS Diluted | -7.46% | 56.06% | |||
| Normalized Diluted EPS | -40.16% | 61.75% | |||
| Average Basic Shares Outstanding | 41.59% | 21.43% | |||
| Average Diluted Shares Outstanding | 41.59% | 21.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
